Marcel de Matas

CMC Consultant (Drug Product), SEDA Pharma Development Services

Marcel de Matas is the co-founder and CTO at Seda Pharmaceutical Development Services, which is focussed on helping biotechnology and drug delivery companies to progress new medicinal products and technologies into clinical development and towards commercialisation.

During his 25-year career, Marcel has held a range of management and senior scientific positions in industry and academia with the last 7 years spent transforming Seda into a fast growing, internationally recognised pharmaceutical development CRO.

During his career, Marcel has provided project leadership and led product development teams responsible for the delivery of drug projects from initial concept design through late-stage development and regulatory submission in readiness for launch. This has included a focus on enabling technologies for drug delivery. He has also led teams at the drug discovery-development interface, assessing the level of chemistry manufacturing and control (CMC) technical risk and defining product design strategies in early development. Project experience has covered molecules across a range of disease and therapy areas with substantial experience in the oncology field.